Literature DB >> 26171595

Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Brian R Edlin1,2, Benjamin J Eckhardt1, Marla A Shu3, Scott D Holmberg4, Tracy Swan5.   

Abstract

UNLABELLED: Data from the 2003-2010 National Health and Nutrition Examination Survey (NHANES) indicate that about 3.6 million people in the United States have antibodies to the hepatitis C virus, of whom 2.7 million are currently infected. NHANES, however, excludes several high-risk populations from its sampling frame, including people who are incarcerated, homeless, or hospitalized; nursing home residents; active-duty military personnel; and people living on Indian reservations. We undertook a systematic review of peer-reviewed literature and sought out unpublished presentations and data to estimate the prevalence of hepatitis C in these excluded populations and in turn improve the estimate of the number of people with hepatitis C in the United States. The available data do not support a precise result, but we estimated that 1.0 million (range 0.4 million-1.8 million) persons excluded from the NHANES sampling frame have hepatitis C virus antibody, including 500,000 incarcerated people, 220,000 homeless people, 120,000 people living on Indian reservations, and 75,000 people in hospitals. Most are men. An estimated 0.8 million (range 0.3 million-1.5 million) are currently infected. Several additional sources of underestimation, including nonresponse bias and the underrepresentation of other groups at increased risk of hepatitis C that are not excluded from the NHANES sampling frame, were not addressed in this study.
CONCLUSION: The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million (range 3.4 million-6.0 million), and of these, at least 3.5 million (range 2.5 million-4.7 million) are currently infected; additional sources of potential underestimation suggest that the true prevalence could well be higher.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26171595      PMCID: PMC4751870          DOI: 10.1002/hep.27978

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  67 in total

1.  Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty.

Authors:  Briana L Calore; Ramsey C Cheung; Nicholas J Giori
Journal:  J Arthroplasty       Date:  2012-07-05       Impact factor: 4.757

2.  The National Nursing Home Survey: 2004 overview.

Authors:  Adrienne L Jones; Lisa L Dwyer; Anita R Bercovitz; Genevieve W Strahan
Journal:  Vital Health Stat 13       Date:  2009-06

3.  Housing instability and health: findings from the Michigan Recession and Recovery Study.

Authors:  Sarah A Burgard; Kristin S Seefeldt; Sarah Zelner
Journal:  Soc Sci Med       Date:  2012-09-01       Impact factor: 4.634

4.  Hepatitis C in the United States.

Authors:  Scott D Holmberg; Philip R Spradling; Anne C Moorman; Maxine M Denniston
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245

5.  Prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a Grand Rapids, Michigan emergency department.

Authors:  Mark R Hall; Dale Ray; Julie A Payne
Journal:  J Emerg Med       Date:  2008-11-08       Impact factor: 1.484

6.  Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.

Authors:  Ponni V Perumalswami; Stephanie H Factor; Luciano Kapelusznik; Scott L Friedman; Calvin Q Pan; Charissa Chang; Frances Di Clemente; Douglas T Dieterich
Journal:  J Hepatol       Date:  2013-01-15       Impact factor: 25.083

7.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

8.  Viral hepatitis in a homeless shelter in Hawai'i.

Authors:  Daniel E C Boyce; Alan D Tice; Fernando V Ona; Kenneth T Akinaka; Heather Lusk
Journal:  Hawaii Med J       Date:  2009-06

Review 9.  Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Authors:  Khayriyyah Mohd Hanafiah; Justina Groeger; Abraham D Flaxman; Steven T Wiersma
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

10.  Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.

Authors:  Barbara Tempalski; Enrique R Pouget; Charles M Cleland; Joanne E Brady; Hannah L F Cooper; H Irene Hall; Amy Lansky; Brooke S West; Samuel R Friedman
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more
  156 in total

1.  Hepatitis C-Related Mortality Among American Indian/Alaska Native Persons in the Northwestern United States, 2006-2012.

Authors:  Sarah M Hatcher; Sujata Joshi; Byron F Robinson; Thomas Weiser
Journal:  Public Health Rep       Date:  2019-11-25       Impact factor: 2.792

2.  Changing trends in complications of chronic hepatitis C.

Authors:  Mei Lu; Jia Li; Loralee B Rupp; Yueren Zhou; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Yihe G Daida; Mark A Schmidt; Sheri Trudeau; Stuart C Gordon
Journal:  Liver Int       Date:  2017-07-21       Impact factor: 5.828

3.  A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma.

Authors:  Jinping Liu; Wei Tang; Anuradha Budhu; Marshonna Forgues; Maria O Hernandez; Julián Candia; Yujin Kim; Elise D Bowman; Stefan Ambs; Yongmei Zhao; Bao Tran; Xiaolin Wu; Christopher Koh; Pallavi Surana; T Jake Liang; Maria Guarnera; Dean Mann; Manoj Rajaure; Tim F Greten; Zhanwei Wang; Herbert Yu; Xin Wei Wang
Journal:  Cell       Date:  2020-06-10       Impact factor: 41.582

Review 4.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Authors:  Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

5.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

6.  Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance.

Authors:  Rachel E Gicquelais; Betsy Foxman; Joseph Coyle; Marisa C Eisenberg
Journal:  Epidemics       Date:  2019-02-28       Impact factor: 4.396

7.  Increasing hepatitis C screening in a large integrated health system: science and policy in concert.

Authors:  Carla V Rodriguez; Kevin B Rubenstein; Benjamin Linas; Haihong Hu; Michael Horberg
Journal:  Am J Manag Care       Date:  2018-05-01       Impact factor: 2.229

8.  Improvements in brain and behavior following eradication of hepatitis C.

Authors:  Taylor Kuhn; Philip Sayegh; Jacob D Jones; Jason Smith; Manoj K Sarma; A Ragin; Elyse J Singer; M Albert Thomas; April D Thames; Steven A Castellon; Charles H Hinkin
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

9.  Trends in liver cancer mortality in the United States: Dual burden among foreign- and US-born persons.

Authors:  Meheret Endeshaw; Benjamin D Hallowell; Hilda Razzaghi; Virginia Senkomago; Matthew T McKenna; Mona Saraiya
Journal:  Cancer       Date:  2018-11-27       Impact factor: 6.860

10.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.